Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- Check13 days agoChange DetectedThe history section documents past submissions and status updates across versions; there are no new textual changes listed.SummaryDifference0.1%

- Check20 days agoChange DetectedA new Revision: v3.6.4 entry was added to the history and the previous Revision: v3.6.3 entry was removed, indicating an updated submission being recorded in the history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe record history adds Revision: v3.6.3 and removes Revision: v3.6.2. This marks a new release version for the history log of the study, without altering the underlying study data.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.6.2 is added to the study record history. The previous revision entry v3.6.0 is removed from the visible history.SummaryDifference0.1%

- Check63 days agoChange DetectedRecruitment status updated to no longer seek participants, indicating enrollment has ended. The study record shows a new revision (v3.6.0) replacing the previous version (v3.5.5).SummaryDifference0.4%

- Check70 days agoChange DetectedA new revision entry v3.5.5 is added to the record history, signaling an updated version of the study record. The prior revision v3.5.4 is removed from the history list.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.